Results 1 to 10 of about 3,767,854 (367)
Drug eruptions with novel targeted therapies - immune checkpoint and EGFR inhibitors. [PDF]
J Dtsch Dermatol Ges, 2021 Given the increasing use of novel targeted therapies, dermatologists are constantly confronted with novel cutaneous side effects of these agents. A rapid diagnosis and appropriate management of these side effects are crucial to prevent impairment of the ...
Pospischil I, Hoetzenecker W.
europepmc +2 more sources
Patch testing in fixed drug eruptions-a 20-year review [PDF]
Contact Dermatitis, 2011 Background. The fixed drug eruption is a common adverse drug reaction. Clear identification of the culprit drug is not always possible in the clinical setting, and oral rechallenge may induce new lesions or severe reactions.
Pedro Andrade +2 more
semanticscholar +5 more sources
Prevalence and Clinical Profile of Drug Eruptions among Antiretroviral Therapy-Exposed HIV Infected People in Yaoundé, Cameroon. [PDF]
Dermatol Res Pract, 2017 Background Prevalence and incidence of drug eruptions vary around the world and are influenced by some key factors including HIV infection. Objective This study aimed to find the peculiarities of drug eruptions in people living with HIV (PLHIV) and on ...
Kouotou EA +5 more
europepmc +2 more sources
Fixed-drug Eruptions: What can we Learn from a Case Series?
Indian J Dermatol, 2018 Background: A fixed-drug eruption (FDE) is a unique cutaneous adverse drug effect in the form of recurrent lesions at the same site after re-exposure to the offending agent.
Jhaj R +3 more
europepmc +2 more sources
DRUG ERUPTIONS FROM THE CLINICAL ASPECT [PDF]
, 1922 Whoever has read Prince A. Morrow's1monograph on drug eruptions will surely sympathize with us in our effort to present the subject of "Drug Eruptions from the Clinical Aspect" with the greatest possible expedition; with Morrow's work before us, we feel ...
Fred Wise
openalex +2 more sources
JAMA Dermatol, 2017 Importance Purpuric skin lesions have only rarely been reported in patients receiving epidermal growth factor receptor inhibitors. However, their clinical and histopathologic presentations have varied considerably. Objective To characterize purpuric skin
Cho YT +6 more
europepmc +2 more sources
Fixed drug eruptions caused by cross-reactive quinolones. [PDF]
J Basic Clin Pharm, 2014 Fixed drug eruptions (FDE) are the common dermatological adverse drug reaction accounts for 16–21% of all cutaneous drug reactions in India. Drugs most frequently implicated in FDE are antimicrobials, anticonvulsants, and nonsteroidal antiinflammatory ...
Kameswari PD, Selvaraj N, Adhimoolam M.
europepmc +2 more sources
Fixed drug eruptions with intraoral presentation.
Indian J Dent, 2015 Fixed-drug eruption (FDE) is an unusual and rare adverse drug reaction. This type of reaction is actually a delayed type of hypersensitivity reaction that occurs as lesions recurring at the same skin site due to repeated intake of an offending drug. Here
Srivastava R +3 more
europepmc +2 more sources